DC Chemicals · Product datasheet

Mavacamten (MYK-461) · DC11524

Mavacamten (MYK-461) is a cardiac myosin inhibitor used to study sarcomere contractility and hypertrophic cardiomyopathy.

ParameterValue
Chemical NameMavacamten
CAS No.1642288-47-8
SynonymsMavacamten; QX45B99R3J; (S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione; Mavacamten [INN]; Mavacamten [WHO-DD]; MYK461; GTPL11265; s8861; SAR439152; DB14921; SB19779; (S)-3-Isopropyl-6-((1-phenylethyl)amino) pyrimidine-2,4(1H,3H)-dione; (S)-3-Isopropyl-6-((1-phenylethyl)amino)pyrimidine-2, 4(1H,3H)-dione; (S)-3-Isopropyl-6
FormulaC15N3O2H19
M.Wt273.3303
SMILESO=C1N([H])C(=C([H])C(N1C([H])(C([H])([H])[H])C([H])([H])[H])=O)N([H])[C@@]([H])(C([H])([H])[H])C1C([H])=C([H])C([H])=C([H])C=1[H]
Purity98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity summary

Mavacamten (MYK-461) is a cardiac myosin inhibitor used to study sarcomere contractility and hypertrophic cardiomyopathy.

View referenced In Vitro and In Vivo results on the product page

References

  1. Green EM, et al. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science (New York, N.Y.) (2016).

Available packs

  • 100 mg · US$550
  • 250 mg · US$900
  • 1 g · US$1,800
  • 10 mM * 1 mL in DMSO · US$220
View product and biological activity →

Cart

Request quotation